Risk factors for medication-related osteonecrosis of the jaw and salivary IL-6 IN cancer patients

Risk factors for medication-related osteonecrosis of the jaw and salivary IL-6 IN cancer patients

Introduction: Medication-related osteonecrosis of the jaws is a severe complication of the use of antiresorptive and antiangiogenic therapy, with limited treatment options and great impact on patient’s quality pf life. Objective: The aim of this study was to assess the risk factors associated with m...

Full description

Bibliographic Details
Main Authors:	Aristilia Pricila Tahara Kemp, Vitor Hugo Candido Ferreira, Rafael Zancan Mobile, Thais Bianca Brandão, Laurindo Moacir Sassi, Amanda Zarpellon, Paulo Henrique Braz-Silva, Juliana Lucena Schussel
Format:	Article
Language:	English
Published:	Elsevier 2022-09-01
Series:	Brazilian Journal of Otorhinolaryngology
Subjects:	Bisphosphonates Osteonecrosis of the jaw Biomarkers in saliva Interleukin-6
Online Access:	http://www.sciencedirect.com/science/article/pii/S1808869420301762

Similar Items

Bisphosphonate-Related Osteonecrosis of the Jaws. A Severe Side Effect of Bisphosphonate Therapy
by: Zuzana Janovská
Published: (2012-01-01)

Bisphosphonates and osteonecrosis of jaws
by: Geetha Vijay, et al.
Published: (2012-01-01)

Surgical management in patients with bisphosphonate-related osteonecrosis of the jaw: four cases
by: Emre Dikicier, et al.
Published: (2014-12-01)

Bisphosphonate - Related Osteonecrosis of the Jaw – Five Years Experience
by: Stilla J, et al.
Published: (2013-11-01)

Experience with the treatment of bisphosphonate-related osteonecrosis of the jaw
by: Zuzana Janovska, et al.
Published: (2015-06-01)

<i>ONJ (MRONJ) Update 2021</i>—Osteonecrosis of Jaw Related to Bisphosphonates and Other Drugs—Prevention, Diagnosis, Pharmacovigilance, Treatment: A 2021 Web Event
by: Vittorio Fusco, et al.
Published: (2022-04-01)

Topical erythropoietin as a novel preventive and therapeutic agent in bisphosphonate-related osteonecrosis of the jaw
by: Pantea Nazeman, et al.
Published: (2016-01-01)

The Role of the Immune Response in the Development of Medication-Related Osteonecrosis of the Jaw
by: Weidong Zhang, et al.
Published: (2021-02-01)

Review of the effect of biphosphonates on jaw osteonecrosis
by: Afshin Tahmasebi, et al.
Published: (2011-01-01)

Bisphosphonate-related osteonecrosis of the jaw: specificities
by: Siri Paulo, et al.
Published: (2014-09-01)

A systematic review of microsurgical reconstruction of the jaws using vascularized fibula flap technique in patients with bisphosphonate-related osteonecrosis
by: Roberto Sacco, et al.
Published: (2011-08-01)

Medication-Related Osteonecrosis of the Jaws (MRONJ): Etiological Update
by: Gianluca Tenore, et al.
Published: (2014-12-01)

Epidemiological aspects of rheumatoid arthritis patients affected by oral bisphosphonate-related osteonecrosis of the jaws
by: Conte-Neto Nicolau, et al.
Published: (2012-03-01)

BISPHOSPHONATES RELATED OSTEONECROSIS OF THE JAW IN CANCER PATIENTS – EPIDEMIOLOGICAL STUDY
by: George Adrian Ciobanu, et al.
Published: (2022-08-01)

Development of Osteonecrosis of the Jaw in a Patient Receiving Oral Bisphosphonates for Osteoporosis: A Case Report
by: Sina Esmaeilzadeh, et al.
Published: (2014-08-01)

Bisphosphonates and Their Connection to Dental Procedures: Exploring Bisphosphonate-Related Osteonecrosis of the Jaws
by: Emily Sunny Lee, et al.
Published: (2023-11-01)

A Case of Autoimmune Hepatitis and Bisphosphonate-Related Osteonecrosis of the Jaw
by: Y.S. de Boer, et al.
Published: (2012-05-01)

Evaluation of Jaw Osteonecrosis Following Intra-Ligament Anesthesia in Zoledronate-Treated Rats: a Histological Evaluation
by: Saeed Moradi, et al.
Published: (2023-03-01)

RANK-Ligand inhibitor associated osteonecrosis of the jaw
by: Rashad, Ashkan, et al.
Published: (2013-11-01)

OSTEONECROSIS OF THE JAW ASSOCIATED WITH SHORT-COURSE AND LOW-DOSE CORTICOSTEROID THERAPY
by: Lavinia Cristina Pădurariu, et al.
Published: (2023-12-01)

Characteristics of patients with osteonecrosis of the jaw with oral versus intravenous bisphosphonate treatment
by: Seung-Hun Lee, et al.
Published: (2021-07-01)

Bisphosphonate-related osteonecrosis of the jaws: Report of two cases with breast cancer, a dental concern and review of the literature
by: Ahmet Ercan Şekerci, et al.
Published: (2012-07-01)

Medication‐related osteonecrosis of the jaw leading to sepsis in a patient with rheumatoid arthritis: A case report and clinical implications
by: Kazuhiko Iwasaki, et al.
Published: (2023-06-01)

Clinical profile of individuals with bisphosphonate-related osteonecrosis of the jaw: an integrative review
by: Aloizio Premoli Maciel, et al.
Published: (2020-07-01)

Microscopic Evaluation of the Effect of Oral Microbiota on the Development of Bisphosphonate-Related Osteonecrosis of the Jaws in Rats
by: Felipe M. Silveira, et al.
Published: (2017-01-01)

Systematic Review on the Incidence of Bisphosphonate Related Osteonecrosis of the Jaw in Children Diagnosed with Osteogenesis Imperfecta
by: Anusha Adeline Hennedige, et al.
Published: (2014-01-01)

Epi-Mucosa Fixation and Autologous Platelet-Rich Fibrin Treatment in Medication-Related Osteonecrosis of the Jaw
by: Antonio Cortese, et al.
Published: (2021-04-01)

Therapeutic Effect of Benidipine on Medication-Related Osteonecrosis of the Jaw
by: Ken Matsunaka, et al.
Published: (2022-08-01)

Spontaneous bisphosphonate-related osteonecrosis of the left hemi-mandible: Similarities with phossy jaw
by: Giuseppina Campisi, et al.
Published: (2012-01-01)

Are medication-induced salivary changes the culprit of osteonecrosis of the jaw? A systematic review
by: Isti Rahayu Suryani, et al.
Published: (2023-08-01)

What Do Prescribers of Bone Modifying Agents Know about Medication-Related Osteonecrosis of the Jaw? Is Current Prevention Enough?
by: Mihai Vlad Golu, et al.
Published: (2022-09-01)

Medication-related osteonecrosis of the jaw after dental clearance: Prevalence in an oncology center
by: Saad Hajeri, BDS, et al.
Published: (2022-09-01)

ADVANCED-PLATELET RICH FIBRIN – A NEW ACQUISITION IN JAW OSTEONECROSIS TREATMENT
by: Daniel Vlad, et al.
Published: (2018-01-01)

Strontium ranelate treatment in a postmenopausal woman with osteonecrosis of the jaw after long-term oral bisphosphonate administration: a case report
by: Pan WL, et al.
Published: (2017-07-01)

Histopathological assessment of the preventive effect of leukocyte-platelet-rich fibrin on bisphosphonate-related osteonecrosis of the jaw following dental extraction: An animal study
by: Milad Etemadi Sh, et al.
Published: (2023-07-01)

Impact of Soft Tissue Pathophysiology in the Development and Maintenance of Bisphosphonate-Related Osteonecrosis of the Jaw (BRONJ)
by: Thomas Ziebart, et al.
Published: (2016-10-01)

Autologous Platelet-Rich Fibrin (PRF) as an Adjunct in the Management of Osteoradionecrosis and Medication-Related Osteonecrosis of Jaws. Case Series in A Single Centre
by: Benjie Law, et al.
Published: (2021-04-01)

Serum VEGF levels as predictive marker of bisphosphonate-related osteonecrosis of the jaw
by: Vincenzi Bruno, et al.
Published: (2012-09-01)

Osteonecrosis of the jaw after dental implant placement. A case report
by: J.L. Calvo-Guirado, et al.
Published: (2014-03-01)

Treatment with teriparatide for advanced bisphosphonate-related osteonecrosis of the jaw around dental implants: a case report
by: Yusuke Zushi, et al.
Published: (2017-03-01)